Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 1991;22:1064-1067

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marinov, M.
Right arrow Articles by Wassmann, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marinov, M.
Right arrow Articles by Wassmann, H.

Stroke, Vol 22, 1064-1067, Copyright © 1991 by American Heart Association


ARTICLES

Lack of effect of PN 200-110 on neuronal injury and neurological outcome in middle cerebral artery-occluded rats

M Marinov and H Wassmann
Department of Neurosurgery, Medical Academy, Sofia, Bulgaria.

We evaluated the influence of a continuous intravenous infusion of 0.24 mg/kg PN 200-110 started 20 minutes before the induction of ischemia and continued for 2 hours on infarct size, histopathology, and neurological outcome in middle cerebral artery-occluded rats treated with PN 200-110 (n = 8), placebo (n = 7), or saline (n = 8). Neurological examination was performed 24 hours after occlusion. We quantified infarct size by 2,3,5-triphenyl-tetrazolium chloride, hematoxylin and eosin, and Nissl staining and by computerized analysis of tracings of the infarcted areas and evaluated neuronal injury at the infarct periphery. The different types of ischemic cell damage were quantified by direct visual counting. We found no differences among saline-, placebo-, and PN 200-110-treated rats regarding infarct size, amount of neuronal alteration, and neurological outcome. Our results indicate the lack of a significant protective effect of this drug in experimental focal ischemia.


This article has been cited by other articles:


Home page
StrokeHome page
S. J. Bailey, N. I. Wood, N. A. Samson, A. L. Rothaul, J. C. Roberts, P. D. King, T. C. Hamilton, D. C. Harrison, and A. J. Hunter
Failure of Isradipine to Reduce Infarct Size in Mouse, Gerbil, and Rat Models of Cerebral Ischemia
Stroke, November 1, 1995; 26(11): 2177 - 2183.
[Abstract] [Full Text]